These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11569956)

  • 1. FDA gives salvage therapy testing a push forward.
    Bass E
    AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
    AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA meeting on approving immune therapies: background and comment.
    James JS
    AIDS Treat News; 2000 Oct; (353):3-7. PubMed ID: 12173555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testimony on accelerated approval.
    Hogan C
    GMHC Treat Issues; 2003 Nov; 17(11):12. PubMed ID: 14717108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 7. An FDA-ok'd viral load test? The wait may be nearly over. Food and Drug Administration.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):6-9. PubMed ID: 11363333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3TC receives full approval.
    Grodeck B; Vazquez E
    Posit Aware; 1997; 8(3):11. PubMed ID: 11364417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
    [No Abstract]   [Full Text] [Related]  

  • 12. Integration of salvage research into existing networks and structures.
    Evans D
    Res Initiat Treat Action; 2004; 10(1):22-3. PubMed ID: 15595168
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starving the virus.
    Res Initiat Treat Action; 1999 Apr; 5(2):32-3. PubMed ID: 11366283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract]   [Full Text] [Related]  

  • 16. On approval.
    Huff B
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HIV therapy update.
    Proj Inf Perspect; 2002 Mar; (34):4-6. PubMed ID: 12038301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs in the fight against HIV disease.
    Rosenthal E
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract]   [Full Text] [Related]  

  • 20. The science and marketing of simpler dosing.
    Proj Inf Perspect; 1997 Nov; (23):6-7. PubMed ID: 11365380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.